Levofloxacin Eye Drops Approved by the NMPA

Kangrong Pharmaceutical has received the Drug Registration Certificate for Levofloxacin Eye Drops issued by the National Medical Products Administration (NMPA), with the drug approval number NMPA Approval No. H20264702.

Levofloxacin Eye Drops, strength: 0.488% (5 mL: 24.4 mg) (calculated as C₁₈H₂₀FN₃O₄), are primarily indicated for the treatment of blepharitis, hordeolum, dacryocystitis, conjunctivitis, meibomianitis, and keratitis, as well as for antimicrobial prophylaxis during the perioperative period in ophthalmic surgery.

First published: 15 June, 2026